bioglobal, page-6

Guessing it may be worth a couple of cents to CNN s/p initially when it floats depending on float price 20c,50c, $1.00 . $3.8m, $9.5m, $19m take your pick but will be nice little backing for CNN especially if the new floated co heads north.

Progress on Bioglobal has been kept well off the radar for years now and I personally can testify to that as I visited their Wacol office in 2003 and spoke personnally to present CEO Ken Ingbritsen about the whole setup of CNN.
One could assume 7 years later after a couple of capital raisings Bioglobal should have made headway in the development, trials and sales of their products.

Sugarbowls assessment is very heartening.

This is the dark horse I believe which may furthur enhance CNN's position in near future.

My opinion only.